TreeWAS – Variant ID: rs10891354

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T43.2 Other and unspecified antidepressants	0.000	0.962	0.038
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.967	0.033
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.968	0.032
T43.6 Psychostimulants with abuse potential	0.000	0.972	0.028
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.972	0.028
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.974	0.026
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.976	0.024
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.976	0.024
T43.9 Psychotropic drug, unspecified	0.000	0.977	0.023
F81.9 Developmental disorder of scholastic skills, unspecified	0.023	0.977	0.000
M54.16 Radiculopathy (Lumbar region)	0.017	0.983	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.983	0.017
F81 Specific developmental disorders of scholastic skills	0.012	0.988	0.000
Y54.3 Benzothiadiazine derivatives	0.000	0.988	0.012
R18 Ascites	0.000	0.989	0.011
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.000	0.990	0.010
Y54.8 Agents affecting uric acid metabolism	0.000	0.991	0.009
F81.8 Other developmental disorders of scholastic skills	0.009	0.991	0.000
F81.3 Mixed disorder of scholastic skills	0.009	0.991	0.000
F81.2 Specific disorder of arithmetical skills	0.009	0.991	0.000
F81.1 Specific spelling disorder	0.009	0.991	0.000
F81.0 Specific reading disorder	0.009	0.991	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.000	0.992	0.008
Y54.5 Other diuretics	0.000	0.992	0.008
M54.1 Radiculopathy	0.008	0.992	0.000
Y54.4 Loop [high-ceiling] diuretics	0.000	0.992	0.008
I44.1 Atrioventricular block, second degree	0.000	0.993	0.007
Y54.9 Mineral salts, not elsewhere classified	0.000	0.993	0.007
Y54.6 Electrolytic, caloric and water-balance agents	0.000	0.993	0.007
Y54.2 Carbonic-anhydrase inhibitors	0.000	0.993	0.007
C21.0 Anus, unspecified	0.000	0.993	0.007
C22.1 Intrahepatic bile duct carcinoma	0.000	0.993	0.007
Y54.0 Mineralocorticoids	0.000	0.993	0.006
K35.8 Acute appendicitis, other and unspecified	0.000	0.993	0.006
C21 Malignant neoplasm of anus and anal canal	0.000	0.993	0.006
K35.9 Acute appendicitis, unspecified	0.000	0.994	0.006
C21.8 Overlapping lesion of rectum, anus and anal canal	0.000	0.994	0.006
Y54.7 Agents affecting calcification	0.000	0.994	0.006
M54.19 Radiculopathy (Site unspecified)	0.006	0.994	0.000
K35.1 Acute appendicitis with peritoneal abscess	0.000	0.994	0.006
M54.15 Radiculopathy (Thoracolumbar region)	0.006	0.994	0.000
M54.13 Radiculopathy (Cervicothoracic region)	0.006	0.994	0.000
M54.11 Radiculopathy (Occipito-atlanto-axial region)	0.006	0.994	0.000
M54.10 Radiculopathy (Multiple sites in spine)	0.006	0.994	0.000
K35 Acute appendicitis	0.000	0.994	0.006
M54.12 Radiculopathy (Cervical region)	0.006	0.994	0.000
C21.1 Anal canal	0.000	0.994	0.006
M54.17 Radiculopathy (Lumbosacral region)	0.006	0.994	0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.000	0.994	0.006
D22.6 Melanocytic naevi of upper limb, including shoulder	0.006	0.994	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.995	0.005
M54.14 Radiculopathy (Thoracic region)	0.005	0.995	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.995	0.005
C22.9 Liver, unspecified	0.000	0.995	0.005
S02.40 Fracture of malar and maxillary bones (closed)	0.005	0.995	0.000
H34.8 Other retinal vascular occlusions	0.000	0.995	0.005
I46.0 Cardiac arrest with successful resuscitation	0.000	0.995	0.005
M54.4 Lumbago with sciatica	0.005	0.995	0.000
M54 Dorsalgia	0.005	0.995	0.000
C21.2 Cloacogenic zone	0.000	0.995	0.005
D41.0 Kidney	0.000	0.995	0.005
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.995	0.005
R22.4 Localised swelling, mass and lump, lower limb	0.005	0.995	0.000
M54.46 Lumbago with sciatica (Lumbar region)	0.005	0.995	0.000
C22.0 Liver cell carcinoma	0.000	0.995	0.005
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.995	0.005
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.995	0.005
M54.9 Dorsalgia, unspecified	0.005	0.995	0.000
M54.96 Dorsalgia, unspecified (Lumbar region)	0.004	0.996	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.996	0.004
M89.88 Other specified disorders of bone (Other)	0.000	0.996	0.004
F80-F89 Disorders of psychological development	0.004	0.996	0.000
T42.0 Hydantoin derivatives	0.000	0.996	0.004
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.996	0.004
M54.18 Radiculopathy (Sacral and sacrococcygeal region)	0.004	0.996	0.000
M54.90 Dorsalgia, unspecified (Multiple sites in spine)	0.004	0.996	0.000
C22.7 Other specified carcinomas of liver	0.000	0.996	0.004
C22.4 Other sarcomas of liver	0.000	0.996	0.004
C22.3 Angiosarcoma of liver	0.000	0.996	0.004
C22.2 Hepatoblastoma	0.000	0.996	0.004
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.996	0.004
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.996	0.004
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.996	0.004
M54.49 Lumbago with sciatica (Site unspecified)	0.004	0.996	0.000
M54.98 Dorsalgia, unspecified (Sacral and sacrococcygeal region)	0.004	0.996	0.000
D17.3 Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites	0.000	0.996	0.004
T47.0 Histamine H(2)-receptor antagonists	0.000	0.996	0.004
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.996	0.004
M54.3 Sciatica	0.004	0.996	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.996	0.004
T47.4 Other laxatives	0.000	0.996	0.004
T47.2 Stimulant laxatives	0.000	0.996	0.004
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.996	0.004
M54.47 Lumbago with sciatica (Lumbosacral region)	0.004	0.996	0.000
M54.37 Sciatica (Lumbosacral region)	0.004	0.996	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.996	0.004
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.996	0.004
T47.7 Emetics	0.000	0.996	0.004
T47.6 Antidiarrhoeal drugs	0.000	0.996	0.004
T47.5 Digestants	0.000	0.996	0.004
T47.3 Saline and osmotic laxatives	0.000	0.996	0.004
K35.2 Acute appendicitis with generalized peritonitis	0.000	0.996	0.004
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.996	0.004
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.996	0.004
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.996	0.004
M54.48 Lumbago with sciatica (Sacral and sacrococcygeal region)	0.004	0.996	0.000
M54.45 Lumbago with sciatica (Thoracolumbar region)	0.004	0.996	0.000
M54.44 Lumbago with sciatica-Thoracic	0.004	0.996	0.000
M54.43 Lumbago with sciatica-Cervicothoracic	0.004	0.996	0.000
M54.42 Lumbago with sciatica-Cervical	0.004	0.996	0.000
M54.41 Lumbago with sciatica-Occipit-atl-axl	0.004	0.996	0.000
M54.40 Lumbago with sciatica (Multiple sites in spine)	0.004	0.996	0.000
M54.0 Panniculitis affecting regions of neck and back	0.004	0.996	0.000
M54.6 Pain in thoracic spine	0.004	0.996	0.000
D86.9 Sarcoidosis, unspecified	0.004	0.996	0.000
K35.3 Acute appendicitis with localized peritonitis	0.000	0.996	0.004
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.996	0.004
M54.97 Dorsalgia, unspecified (Lumbosacral region)	0.004	0.996	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.996	0.004
T46.1 Calcium-channel blockers	0.000	0.996	0.004
T42.3 Barbiturates	0.000	0.996	0.004
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.996	0.003
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.996	0.003
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.996	0.003
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.996	0.003
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.996	0.003
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.996	0.003
T44.0 Anticholinesterase agents	0.000	0.996	0.003
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.996	0.004
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.996	0.003
T46.7 Peripheral vasodilators	0.000	0.996	0.003
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.996	0.003
M54.91 Dorsalgia, unspecified (Occipito-atlanto-axial region)	0.003	0.996	0.000
F84 Pervasive developmental disorders	0.003	0.996	0.000
T38.1 Thyroid hormones and substitutes	0.000	0.996	0.003
M54.92 Dorsalgia, unspecified (Cervical region)	0.003	0.997	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.997	0.003
T42.2 Succinimides and oxazolidinediones	0.000	0.997	0.003
F89 Unspecified disorder of psychological development	0.003	0.997	0.000
F88 Other disorders of psychological development	0.003	0.997	0.000
F83 Mixed specific developmental disorders	0.003	0.997	0.000
F82 Specific developmental disorder of motor function	0.003	0.997	0.000
M54.30 Sciatica (Multiple sites in spine)	0.003	0.997	0.000
N30.9 Cystitis, unspecified	0.000	0.997	0.003
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.997	0.003
T37.5 Antiviral drugs	0.000	0.997	0.003
T37.4 Anthelminthics	0.000	0.997	0.003
T37.3 Other antiprotozoal drugs	0.000	0.997	0.003
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.997	0.003
T37.1 Antimycobacterial drugs	0.000	0.997	0.003
T37.0 Sulphonamides	0.000	0.997	0.003
T42.1 Iminostilbenes	0.000	0.997	0.003
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.997	0.003
M54.95 Dorsalgia, unspecified (Thoracolumbar region)	0.003	0.997	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.997	0.003
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.997	0.003
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.997	0.003
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.997	0.003
T49.9 Topical agent, unspecified	0.000	0.997	0.003
T49.8 Other topical agents	0.000	0.997	0.003
T49.7 Dental drugs, topically applied	0.000	0.997	0.003
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.997	0.003
T49.5 Ophthalmological drugs and preparations	0.000	0.997	0.003
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.997	0.003
T49.3 Emollients, demulcents and protectants	0.000	0.997	0.003
T49.2 Local astringents and local detergents	0.000	0.997	0.003
T49.1 Antipruritics	0.000	0.997	0.003
M54.36 Sciatica (Lumbar region)	0.003	0.997	0.000
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.000	0.997	0.003
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.997	0.003
T48.4 Expectorants	0.000	0.997	0.003
T48.3 Antitussives	0.000	0.997	0.003
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.997	0.003
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.997	0.003
T48.0 Oxytocic drugs	0.000	0.997	0.003
S02.4 Fracture of malar and maxillary bones	0.003	0.997	0.000
W21.9 Unspecified place	0.003	0.997	0.000
Y84.0 Cardiac catheterisation	0.000	0.997	0.003
O36.9 Maternal care for foetal problem, unspecified	0.003	0.997	0.000
T41.5 Therapeutic gases	0.000	0.997	0.003
T41.4 Anaesthetic, unspecified	0.000	0.997	0.003
T41.3 Local anaesthetics	0.000	0.997	0.003
T41.1 Intravenous anaesthetics	0.000	0.997	0.003
T41.0 Inhaled anaesthetics	0.000	0.997	0.003
M54.35 Sciatica (Thoracolumbar region)	0.003	0.997	0.000
M54.34 Sciatica-Thoracic	0.003	0.997	0.000
M54.33 Sciatica-Cervicothoracic	0.003	0.997	0.000
M54.32 Sciatica-Cervical	0.003	0.997	0.000
M54.31 Sciatica-Occipit-atl-axl	0.003	0.997	0.000
R46.2 Strange and inexplicable behaviour	0.003	0.997	0.000
T48.5 Anti-common-cold drugs	0.000	0.997	0.003
T36 Poisoning by systemic antibiotics	0.000	0.997	0.003
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.997	0.003
M54.58 Low back pain (Sacral and sacrococcygeal region)	0.003	0.997	0.000
M54.93 Dorsalgia, unspecified (Cervicothoracic region)	0.003	0.997	0.000
K35-K38 Diseases of appendix	0.000	0.997	0.003
T41.2 Other and unspecified general anaesthetics	0.000	0.997	0.003
M54.63 Pain in thoracic spine (Cervicothoracic region)	0.003	0.997	0.000
M89.87 Other specified disorders of bone (Ankle and foot)	0.000	0.997	0.003
D22.2 Melanocytic naevi of ear and external auricular canal	0.003	0.997	0.000
M89.8 Other specified disorders of bone	0.000	0.997	0.003
M54.94 Dorsalgia, unspecified (Thoracic region)	0.003	0.997	0.000
T38.9 Other and unspecified hormone antagonists	0.000	0.997	0.003
T38.7 Androgens and anabolic congeners	0.000	0.997	0.003
T38.5 Other oestrogens and progestogens	0.000	0.997	0.003
T38.4 Oral contraceptives	0.000	0.997	0.003
T38.2 Antithyroid drugs	0.000	0.997	0.003
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.003
M54.09 Panniculitis affecting regions of neck and back (Site unspecified)	0.003	0.997	0.000
M54.08 Panniculitis affecting regions of neck and back (Sacral and sacrococcygeal region)	0.003	0.997	0.000
M54.07 Panniculitis affecting regions of neck and back (Lumbosacral region)	0.003	0.997	0.000
M54.06 Panniculitis affecting regions of neck and back (Lumbar region)	0.003	0.997	0.000
M54.05 Panniculitis affecting regions of neck and back (Thoracolumbar region)	0.003	0.997	0.000
M54.04 Panniculitis affecting regions of neck and back (Thoracic region)	0.003	0.997	0.000
M54.03 Panniculitis affecting regions of neck and back (Cervicothoracic region)	0.003	0.997	0.000
M54.02 Panniculitis affecting regions of neck and back (Cervical region)	0.003	0.997	0.000
M54.01 Panniculitis affecting regions of neck and back (Occipito-atlanto-axial region)	0.003	0.997	0.000
M54.00 Panniculitis affecting regions of neck and back (Multiple sites in spine)	0.003	0.997	0.000
D22 Melanocytic naevi	0.003	0.997	0.000
D22.4 Melanocytic naevi of scalp and neck	0.003	0.997	0.000
T38.0 Glucocorticoids and synthetic analogues	0.000	0.997	0.003
M54.69 Pain in thoracic spine-Site unspe	0.003	0.997	0.000
M54.68 Pain in thoracic spine-Sacral/sacrococ	0.003	0.997	0.000
M54.67 Pain in thoracic spine-Lumbosacral	0.003	0.997	0.000
M54.66 Pain in thoracic spine-Lumbar	0.003	0.997	0.000
M54.62 Pain in thoracic spine-Cervical	0.003	0.997	0.000
M54.61 Pain in thoracic spine-Occipit-atl-axl	0.003	0.997	0.000
M54.60 Pain in thoracic spine (Multiple sites in spine)	0.003	0.997	0.000
F80 Specific developmental disorders of speech and language	0.003	0.997	0.000
M54.65 Pain in thoracic spine (Thoracolumbar region)	0.003	0.997	0.000
D22.1 Melanocytic naevi of eyelid, including canthus	0.003	0.997	0.000
I95.9 Hypotension, unspecified	0.000	0.997	0.003
R46.0 Very low level of personal hygiene	0.003	0.997	0.000
R46 Symptoms and signs involving appearance and behaviour	0.003	0.997	0.000
K63.2 Fistula of intestine	0.000	0.997	0.003
D86.0 Sarcoidosis of lung	0.003	0.997	0.000
M54.38 Sciatica (Sacral and sacrococcygeal region)	0.003	0.997	0.000
H40.0 Glaucoma suspect	0.003	0.997	0.000
S02.41 Fracture of malar and maxillary bones (open)	0.003	0.997	0.000
R46.8 Other symptoms and signs involving appearance and behaviour	0.003	0.997	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.997	0.003
T50.4 Drugs affecting uric acid metabolism	0.000	0.997	0.003
M89.89 Other specified disorders of bone (Site unspecified)	0.000	0.997	0.003
M54.8 Other dorsalgia	0.003	0.997	0.000
Y84.2 Radiological procedure and radiotherapy	0.000	0.997	0.003
F84.5 Asperger's syndrome	0.003	0.997	0.000
M54.5 Low back pain	0.003	0.997	0.000
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.000	0.997	0.003
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.997	0.003
C24.1 Ampulla of Vater	0.000	0.997	0.003
R46.4 Slowness and poor responsiveness	0.003	0.997	0.000
F84.9 Pervasive developmental disorder, unspecified	0.003	0.997	0.000
F84.8 Other pervasive developmental disorders	0.003	0.997	0.000
F84.4 Overactive disorder associated with mental retardation and stereotyped movements	0.003	0.997	0.000
F84.3 Other childhood disintegrative disorder	0.003	0.997	0.000
F84.2 Rett's syndrome	0.003	0.997	0.000
F84.1 Atypical autism	0.003	0.997	0.000
F84.0 Childhood autism	0.003	0.997	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.997	0.003
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.997	0.003
M54.64 Pain in thoracic spine (Thoracic region)	0.003	0.997	0.000
C24.9 Biliary tract, unspecified	0.000	0.997	0.003
C82.2 Large cell, follicular	0.000	0.997	0.003
G47.9 Sleep disorder, unspecified	0.000	0.997	0.003
T50.1 Loop [high-ceiling] diuretics	0.000	0.997	0.003
D86 Sarcoidosis	0.003	0.997	0.000
K36 Other appendicitis	0.000	0.997	0.003
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.997	0.003
D41.2 Ureter	0.000	0.997	0.003
D41.1 Renal pelvis	0.000	0.997	0.003
S32.50 Fracture of pubis (closed)	0.003	0.997	0.000
N71.9 Inflammatory disease of uterus, unspecified	0.000	0.997	0.003
T50.7 Analeptics and opioid receptor antagonists	0.000	0.997	0.003
T50.5 Appetite depressants	0.000	0.997	0.003
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.997	0.003
T50.0 Mineralocorticoids and their antagonists	0.000	0.997	0.003
D22.9 Melanocytic naevi, unspecified	0.003	0.997	0.000
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.003	0.997	0.000
D41.9 Urinary organ, unspecified	0.000	0.997	0.003
D41.7 Other urinary organs	0.000	0.997	0.003
D41.3 Urethra	0.000	0.997	0.003
K37 Unspecified appendicitis	0.000	0.997	0.003
E80.4 Gilbert's syndrome	0.000	0.997	0.003
M54.2 Cervicalgia	0.003	0.997	0.000
T36.9 Systemic antibiotic, unspecified	0.000	0.997	0.002
T36.7 Antifungal antibiotics, systemically used	0.000	0.997	0.002
T36.6 Rifamycins	0.000	0.997	0.002
T36.5 Aminoglycosides	0.000	0.997	0.002
T36.2 Chloramphenicol group	0.000	0.997	0.002
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.997	0.002
M89.86 Other specified disorders of bone (Lower leg)	0.000	0.997	0.002
D22.0 Melanocytic naevi of lip	0.003	0.997	0.000
T36.8 Other systemic antibiotics	0.000	0.997	0.002
M89.81 Other specified disorders of bone (Shoulder region)	0.000	0.997	0.002
S02.60 Fracture of mandible (closed)	0.003	0.997	0.000
T36.4 Tetracyclines	0.000	0.997	0.002
M89.82 Other specified disorders of bone (Upper arm)	0.000	0.997	0.002
M89.80 Other specified disorders of bone (Multiple sites)	0.000	0.997	0.002
C17.9 Small intestine, unspecified	0.000	0.997	0.002
M89.83 Other specified disorders of bone (Forearm)	0.000	0.998	0.002
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.998	0.002
M89.84 Other specified disorders of bone (Hand)	0.000	0.998	0.002
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.000	0.998	0.002
T36.3 Macrolides	0.000	0.998	0.002
M54.50 Low back pain (Multiple sites in spine)	0.002	0.998	0.000
D41.4 Bladder	0.000	0.998	0.002
C24.0 Extrahepatic bile duct	0.000	0.998	0.002
F80.9 Developmental disorder of speech and language, unspecified	0.002	0.998	0.000
F80.8 Other developmental disorders of speech and language	0.002	0.998	0.000
F80.3 Acquired aphasia with epilepsy [Landau-Kleffner]	0.002	0.998	0.000
F80.0 Specific speech articulation disorder	0.002	0.998	0.000
G30.9 Alzheimer's disease, unspecified	0.000	0.998	0.002
R46.7 Verbosity and circumstantial detail obscuring reason for contact	0.002	0.998	0.000
R46.6 Undue concern and preoccupation with stressful events	0.002	0.998	0.000
R46.5 Suspiciousness and marked evasiveness	0.002	0.998	0.000
R46.3 Overactivity	0.002	0.998	0.000
R46.1 Bizarre personal appearance	0.002	0.998	0.000
T40.4 Other synthetic narcotics	0.000	0.998	0.002
T50.8 Diagnostic agents	0.000	0.998	0.002
M54.88 Other dorsalgia (Sacral and sacrococcygeal region)	0.002	0.998	0.000
D46.7 Other myelodysplastic syndromes	0.000	0.998	0.002
M53.38 Sacrococcygeal disorders, not elsewhere classified-Sacral/s	0.002	0.998	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.998	0.002
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.998	0.002
K38 Other diseases of appendix	0.000	0.998	0.002
M54.21 Cervicalgia (Occipito-atlanto-axial region)	0.002	0.998	0.000
E07.8 Other specified disorders of thyroid	0.000	0.998	0.002
H01.0 Blepharitis	0.000	0.998	0.002
Z74.1 Need for assistance with personal care	0.000	0.998	0.002
M54.53 Low back pain-Cervicothoracic	0.002	0.998	0.000
M54.51 Low back pain-Occipit-atl-axl	0.002	0.998	0.000
M54.85 Other dorsalgia (Thoracolumbar region)	0.002	0.998	0.000
M54.83 Other dorsalgia (Cervicothoracic region)	0.002	0.998	0.000
M54.82 Other dorsalgia (Cervical region)	0.002	0.998	0.000
M54.81 Other dorsalgia (Occipito-atlanto-axial region)	0.002	0.998	0.000
C24.8 Overlapping lesion of biliary tract	0.000	0.998	0.002
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.998	0.002
T45.8 Other primarily systemic and haematological agents	0.000	0.998	0.002
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.998	0.002
T45.6 Fibrinolysis-affecting drugs	0.000	0.998	0.002
T45.4 Iron and its compounds	0.000	0.998	0.002
T45.3 Enzymes, not elsewhere classified	0.000	0.998	0.002
D46 Myelodysplastic syndromes	0.000	0.998	0.002
M54.80 Other dorsalgia (Multiple sites in spine)	0.002	0.998	0.000
D46.9 Myelodysplastic syndrome, unspecified	0.000	0.998	0.002
D86.8 Sarcoidosis of other and combined sites	0.002	0.998	0.000
K65.9 Peritonitis, unspecified	0.000	0.998	0.002
C15-C26 Malignant neoplasms of digestive organs	0.000	0.998	0.002
N71.1 Chronic inflammatory disease of uterus	0.000	0.998	0.002
T42.4 Benzodiazepines	0.000	0.998	0.002
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.000	0.998	0.002
M54.84 Other dorsalgia (Thoracic region)	0.002	0.998	0.000
S01.5 Open wound of lip and oral cavity	0.002	0.998	0.000
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.002	0.998	0.000
H81.2 Vestibular neuronitis	0.000	0.998	0.002
T36.0 Penicillins	0.000	0.998	0.002
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.998	0.002
T40.8 Lysergide [LSD]	0.000	0.998	0.002
T40.7 Cannabis (derivatives)	0.000	0.998	0.002
T40.0 Opium	0.000	0.998	0.002
D86.3 Sarcoidosis of skin	0.002	0.998	0.000
M54.52 Low back pain-Cervical	0.002	0.998	0.000
F80.1 Expressive language disorder	0.002	0.998	0.000
T40.5 Cocaine	0.000	0.998	0.002
T40.3 Methadone	0.000	0.998	0.002
M54.89 Other dorsalgia (Site unspecified)	0.002	0.998	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.000	0.998	0.002
C23 Malignant neoplasm of gallbladder	0.000	0.998	0.002
I46 Cardiac arrest	0.000	0.998	0.002
M54.54 Low back pain-Thoracic	0.002	0.998	0.000
F80.2 Receptive language disorder	0.002	0.998	0.000
R63.8 Other symptoms and signs concerning food and fluid intake	0.000	0.998	0.002
C17 Malignant neoplasm of small intestine	0.000	0.998	0.002
M54.28 Cervicalgia-Sacral/sacrococ	0.002	0.998	0.000
M54.27 Cervicalgia-Lumbosacral	0.002	0.998	0.000
M54.26 Cervicalgia-Lumbar	0.002	0.998	0.000
M54.25 Cervicalgia-Thoracolumbar	0.002	0.998	0.000
M54.24 Cervicalgia-Thoracic	0.002	0.998	0.000
M54.20 Cervicalgia-Mult site	0.002	0.998	0.000
K38.9 Disease of appendix, unspecified	0.000	0.998	0.002
K38.0 Hyperplasia of appendix	0.000	0.998	0.002
Z74.0 Reduced mobility	0.000	0.998	0.002
C26 Malignant neoplasm of other and ill-defined digestive organs	0.000	0.998	0.002
D46.5 Refractory anaemia with multi-lineage dysplasia	0.000	0.998	0.002
M54.56 Low back pain (Lumbar region)	0.002	0.998	0.000
M54.87 Other dorsalgia (Lumbosacral region)	0.002	0.998	0.000
N71 Inflammatory disease of uterus, except cervix	0.000	0.998	0.002
M54.29 Cervicalgia-Site unspe	0.002	0.998	0.000
C26.0 Intestinal tract, part unspecified	0.000	0.998	0.002
H34.1 Central retinal artery occlusion	0.000	0.998	0.002
K38.1 Appendicular concretions	0.000	0.998	0.002
M53.3 Sacrococcygeal disorders, not elsewhere classified	0.002	0.998	0.000
H34 Retinal vascular occlusions	0.000	0.998	0.002
M54.23 Cervicalgia (Cervicothoracic region)	0.002	0.998	0.000
T40.1 Heroin	0.000	0.998	0.002
H81.9 Disorder of vestibular function, unspecified	0.000	0.998	0.002
D37-D48 Neoplasms of uncertain or unknown behaviour	0.000	0.998	0.002
M54.55 Low back pain (Thoracolumbar region)	0.002	0.998	0.000
D86.1 Sarcoidosis of lymph nodes	0.002	0.998	0.000
N70.9 Salpingitis and oophoritis, unspecified	0.000	0.998	0.002
D44.7 Aortic body and other paraganglia	0.000	0.998	0.002
K38.3 Fistula of appendix	0.000	0.998	0.002
G95.2 Cord compression, unspecified	0.002	0.998	0.000
I26.9 Pulmonary embolism without mention of acute cor pulmonale	0.000	0.998	0.002
T45.5 Anticoagulants	0.000	0.998	0.002
C82.3 Follicular lymphoma grade IIIa	0.000	0.998	0.002
D40.1 Testis	0.000	0.998	0.002
T45.2 Vitamins, not elsewhere classified	0.000	0.998	0.002
M54.86 Other dorsalgia (Lumbar region)	0.001	0.998	0.001
D44.6 Carotid body	0.000	0.998	0.002
D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality	0.000	0.998	0.002
D46.3 Refractory anaemia with excess of blasts with transformation	0.000	0.998	0.002
D46.0 Refractory anaemia without sideroblasts, so stated	0.000	0.998	0.002
E85.9 Amyloidosis, unspecified	0.000	0.998	0.002
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.000	0.998	0.002
C82.6 Cutaneous follicle centre lymphoma	0.000	0.998	0.002
C82.5 Diffuse follicle centre lymphoma	0.000	0.998	0.002
D46.1 Refractory anaemia with sideroblasts	0.000	0.998	0.002
J32.0 Chronic maxillary sinusitis	0.002	0.998	0.000
D40 Neoplasm of uncertain or unknown behaviour of male genital organs	0.000	0.998	0.002
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.000	0.998	0.002
C82.4 Follicular lymphoma grade IIIb	0.000	0.998	0.002
D46.2 Refractory anaemia with excess of blasts	0.000	0.998	0.002
N71.0 Acute inflammatory disease of uterus	0.000	0.998	0.002
D45 Polycythaemia vera	0.000	0.998	0.002
M54.39 Sciatica (Site unspecified)	0.002	0.998	0.000
O46.9 Antepartum haemorrhage, unspecified	0.002	0.998	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
M53 Other dorsopathies, not elsewhere classified	0.002	0.998	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.000	0.998	0.002
D37.3 Appendix	0.000	0.998	0.002
S02.6 Fracture of mandible	0.002	0.998	0.000
T45.0 Antiallergic and antiemetic drugs	0.000	0.998	0.002
G30 Alzheimer's disease	0.000	0.998	0.002
M50-M54 Other dorsopathies	0.002	0.998	0.000
C17.8 Overlapping lesion of small intestine	0.000	0.998	0.002
C17.3 Meckel's diverticulum	0.000	0.998	0.002
I46.1 Sudden cardiac death, so described	0.000	0.998	0.002
K07.3 Anomalies of tooth position	0.002	0.998	0.000
O75.7 Vaginal delivery following previous Caesarean section	0.002	0.998	0.000
Z03.6 Observation for suspected toxic effect from ingested substance	0.000	0.998	0.002
Z74 Problems related to care-provider dependency	0.000	0.998	0.002
M89.85 Other specified disorders of bone (Pelvic region and thigh)	0.001	0.998	0.001
D44.9 Endocrine gland, unspecified	0.000	0.998	0.002
G90.3 Multisystem degeneration	0.000	0.998	0.002
Z01.8 Other specified special examinations	0.000	0.998	0.002
G30.1 Alzheimer's disease with late onset	0.000	0.998	0.002
C26.8 Overlapping lesion of digestive system	0.000	0.998	0.002
C26.1 Spleen	0.000	0.998	0.002
D39.1 Ovary	0.000	0.998	0.002
G30.8 Other Alzheimer's disease	0.000	0.998	0.002
K57.8 Diverticular disease of intestine, part unspecified, with perforation and abscess	0.000	0.998	0.002
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.998	0.002
W23.4 Street and highway	0.002	0.998	0.000
Z57.5 Occupational exposure to toxic agents in other industries	0.002	0.998	0.000
D42 Neoplasm of uncertain or unknown behaviour of meninges	0.000	0.998	0.002
H81 Disorders of vestibular function	0.000	0.998	0.002
C45.0 Mesothelioma of pleura	0.002	0.998	0.000
C48.0 Retroperitoneum	0.000	0.998	0.002
M51.9 Intervertebral disk disorder, unspecified	0.002	0.998	0.000
M53.37 Sacrococcygeal disorders, not elsewhere classified-Lumbosac	0.002	0.998	0.000
M53.36 Sacrococcygeal disorders, not elsewhere classified-Lumbar	0.002	0.998	0.000
M53.35 Sacrococcygeal disorders, not elsewhere classified-Thoracol	0.002	0.998	0.000
M53.34 Sacrococcygeal disorders, not elsewhere classified-Thoracic	0.002	0.998	0.000
M53.33 Sacrococcygeal disorders, not elsewhere classified-Cervicot	0.002	0.998	0.000
M53.32 Sacrococcygeal disorders, not elsewhere classified-Cervical	0.002	0.998	0.000
M53.31 Sacrococcygeal disorders, not elsewhere classified-Occipit-	0.002	0.998	0.000
M53.30 Sacrococcygeal disorders, not elsewhere classified-Mult sit	0.002	0.998	0.000
C17.0 Duodenum	0.000	0.998	0.002
H34.0 Transient retinal artery occlusion	0.000	0.998	0.002
W23.2 School, other institution and public administrative area	0.002	0.998	0.000
D37.6 Liver, gallbladder and bile ducts	0.000	0.998	0.002
D44.1 Adrenal gland	0.000	0.998	0.002
K38.2 Diverticulum of appendix	0.000	0.998	0.001
W21 Striking against or struck by sports equipment	0.002	0.998	0.000
D22.5 Melanocytic naevi of trunk	0.002	0.998	0.000
D40.0 Prostate	0.000	0.998	0.002
H01.9 Inflammation of eyelid, unspecified	0.000	0.998	0.002
I46.9 Cardiac arrest, unspecified	0.000	0.998	0.002
M53.39 Sacrococcygeal disorders, not elsewhere classified-Site uns	0.002	0.998	0.000
C82.0 Small cleaved cell, follicular	0.000	0.998	0.002
D39.0 Uterus	0.000	0.998	0.002
T40.6 Other and unspecified narcotics	0.000	0.998	0.001
T88.4 Failed or difficult intubation	0.000	0.998	0.002
Z74.3 Need for continuous supervision	0.000	0.998	0.002
M87.97 Osteonecrosis, unspecified (Ankle and foot)	0.002	0.998	0.000
C26.9 Ill-defined sites within the digestive system	0.000	0.998	0.002
D37.9 Digestive organ, unspecified	0.000	0.998	0.002
H81.8 Other disorders of vestibular function	0.000	0.998	0.002
I78.1 Naevus, nonneoplastic	0.000	0.998	0.002
Z01.5 Diagnostic skin and sensitisation tests	0.000	0.998	0.002
M51 Other intervertebral disk disorders	0.002	0.998	0.000
M87.96 Osteonecrosis, unspecified (Lower leg)	0.002	0.998	0.000
C17.1 Jejunum	0.000	0.998	0.001
D44.8 Pluriglandular involvement	0.000	0.998	0.002
D44.5 Pineal gland	0.000	0.998	0.001
D44.2 Parathyroid gland	0.000	0.998	0.001
D46.4 Refractory anaemia, unspecified	0.000	0.998	0.001
M53.8 Other specified dorsopathies	0.002	0.998	0.000
T40.2 Other opioids	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations